The College of American Pathologists (CAP) electronic Cancer Protocols enable pathologists to use the CAP Cancer Protocols directly within their laboratory information system (AP-LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology AP-LIS vendors offer a CAP electronic Cancer Protocols synoptic module for reporting on surgical cancer resections and selected biopsies.
CAP electronic Cancer Protocols Releases
The CAP releases new and updated electronic Cancer Protocols (eCP) templates on a rolling basis, coordinating as much as possible with the posting of new and revised Cancer Protocols and Cancer Biomarker Reporting Templates. A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP electronic Cancer Protocols users.
Benefits of the CAP electronic Cancer Protocols
Twenty years ago, the CAP worked with leading industry partners to develop the electronic Cancer Protocols to both provide standardized data sets and to enable the synoptic gathering of data within the LIS or as a standalone application.
- Integrates into pathologist AP-LIS workflow
- Supports and aids the pathologist in the diagnostic process
- Standardizes the collection and reporting of cancer patient data
- Facilitates communication between pathologists, clinicians, and cancer registrars
- Helps to advance the pathologist role as chief diagnostician and a leader in the patient care process
- Improves and supports information exchange and data interoperability
- Provides automated access to patient data through work with vendors
CAP electronic Cancer Protocols XML Comparator Tool
The CAP electronic Cancer Protocols XML Comparator tool compares two versions of the electronic Cancer Protocols XML files from the CAP or your local repository. This web-based tool allows for comparison of two versions of the electronic Cancer Protocols to view a "File Comparison Report."
Structure Data Capture (SDC)
SDC is a new technology for representing technology-agnostic forms using SDC schema definition XML format. As of 2019, all electronic Cancer Protocols templates are in SDC format.
Learn more about SDC by reading the SDC System manual that explains SDC web tool navigation, features, and functionality.
Licensing of the CAP electronic Cancer Protocols
The following lists some of the vendors who integrate the CAP electronic Cancer Protocols into their AP-LIS software products:
- Clinisys (Sunquest)
- Epic Beaker
Interfaces and/or integrations with:
- Oracle Cerner Millennium
- Clinisys CoPath Plus
- Clinisys PowerPath
- Other LIS systems
- Oracle Cerner CoPath Plus
- Psyche Systems
Contact the CAP for more information about licensing and using the CAP electronic Cancer Protocols for cancer reporting at your institution.
The CAP electronic Cancer Protocols are now available to users in a standardized software powered by mTuitive.
electronic Cancer Protocols Related Resources
Access resources from the CAP and other organizations to learn more about electronic Cancer Protocols.
Collaboration With Other Organizations
The CAP electronic Cancer Protocols are based on the CAP Cancer Protocols and are produced under the guidance of the CAP Pathology Electronic Reporting (PERT) Committee, along with close interaction and advisement of the Cancer Committee.
CAP electronic Cancer Protocols are developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).
The CAP currently is working with the California Cancer Registry (CCR) to offer the benefits of the CAP electronic Cancer Protocols to California laboratories.
The CAP electronic Cancer Protocols are easy to use, improve efficiency, and remove doubt about report findings. There is clarity of information which is presented in a crisp, consistent format. It gives confidence to health care providers involved in treatment care plans since it is easier and quicker to see the data needed for treatment discussions and decisions.
Dr. Dimitrios Divaris
Chief of pathology at Grand River Hospital and clinical advisor, Cancer Care Ontario
My surgeon provided me a copy of my pathology report. Because of its clarity and completeness, I was then able to research the facts and validate my oncologist's proposed treatment plans. I could truly give informed consent when asked my preference in terms of chemotherapy regimens, radiation therapy, targeted molecular therapy and hormone therapy. Knowing my treatment plan was in line with recommended practice gave me confidence in my health care providers and more importantly, hope for a positive outcome.
Marianne Luettschwager, patient and cancer survivor
Learn more about the other cancer reporting tools.